Articles

Scientists use Clues in the Human Genome to Discover new Inflammatory Syndrome

“Our team of researchers at the NIH discovered a new form of vasculitis  and called it VEXAS. VEXAS is caused by genetic mutations in a portion  of a patient’s blood cells. Before we knew about VEXAS, these patients were diagnosed with other forms of vasculitis, such as relapsing polychondritis, polyarteritis…...

Read more

FDA approves Nucala as the first and only biologic treatment for Hypereosinophilic Syndrome (HES)

Third US indication for Nucala demonstrates GSK’s commitment to finding new ways to help patients with eosinophil-driven diseases Issued: 25 September 2020, London UK GlaxoSmithKline plc (GSK) today announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the treatment of adult and pediatric patients aged 12…...

Read more

VF Announces 2020 V-RED Award Winners

Two winners tied for first place and one received an honorable mention in the Vasculitis Foundation’s (VF) 2020 Recognizing Excellence in Diagnostics (V-RED) award program. Now in its seventh year, the program calls on patients worldwide to nominate a medical professional they want to recognize for making a critical, early…...

Read more

Vasculitis Foundation’s Young Investigator Award Goes to Monash University Research Fellow

Dragana Odobasic, PhD, Research Fellow Monash University, Department of Medicine, Melbourne, Australia Study Title: “Tolerogenic Dendritic Cells for Antigen-Specific Immunosuppression in MPO-ANCA Vasculitis” Investigator: Dragana Odobasic, PhD Co-investigator: Stephen Holdsworth, MD, PhD, Professor, Monash University, Department of Medicine; Head, Clinical Immunology, Monash Health, Clayton, Victoria, Australia Institution: Monash University, Department of Medicine, Centre…...

Read more

VF Announces Young Investigator Award

Dragana Odobasic, PhD, a research fellow at Monash University in Melbourne, Australia, was awarded the Vasculitis Foundation’s (VF) “Dr. Chris Cox-Marinelli Young Investigator Award” in May for her study, Tolerogenic Dendritic Cells for Antigen-Specific Immunosuppression in MPO-ANCA Vasculitis. The award, a one-year grant totaling $49,822, was created in memory of…...

Read more